(TRU) TransUnion - NYSE
Sector: Financial Services | Industry: Financial Data & Stock Exchanges | Exchange: NYSE (USA) | Market Cap: 12.619m USD | Total Return: -21.1% in 12m
Avg Turnover: 126M
EPS Trend: 98.8%
Qual. Beats: 5
Rev. Trend: 99.5%
Qual. Beats: 5
Warnings
Choppy Below Avwap Earnings
Tailwinds
No distinct edge detected
TransUnion (TRU) is a global consumer credit reporting agency providing risk and information solutions across two primary segments: U.S. Markets and International. The company facilitates data-driven decision-making through credit reporting, identity verification, fraud management, and analytic services for industries including financial services, insurance, and retail. Beyond business-to-business services, TransUnion provides credit monitoring and identity protection tools directly to consumers.
As one of the three major national credit bureaus, TransUnion operates within an oligopolistic market structure characterized by high barriers to entry due to the scale of proprietary data required. The business model relies on recurring revenue streams generated by high-volume data requests and subscription-based monitoring services. Investors may find additional insights into these competitive dynamics by reviewing the latest data on ValueRay.
Founded in 1968 and headquartered in Chicago, the firm has expanded its footprint to include specialized solutions for debt recovery, tenant screening, and public sector risk management. Its international operations extend these core capabilities to global markets, supporting credit bureaus and automotive information services across diverse regulatory environments.
- Mortgage market fluctuations impact credit report volume and core revenue growth
- Expansion of fraud and identity solutions diversifies revenue beyond credit reporting
- High interest rates reduce consumer borrowing and loan application processing demand
- International market expansion in emerging economies drives long-term margin improvement
- Regulatory scrutiny over data privacy and credit reporting accuracy impacts compliance costs
| Net Income: 704.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 1.13 > 1.0 |
| NWC/Revenue: 20.56% < 20% (prev 21.84%; Δ -1.28% < -1%) |
| CFO/TA 0.08 > 3% & CFO 1.02b > Net Income 704.6m |
| Net Debt (5.03b) to EBITDA (1.71b): 2.95 < 3 |
| Current Ratio: 1.93 > 1.5 & < 3 |
| Outstanding Shares: last quarter (194.7m) vs 12m ago -1.32% < -2% |
| Gross Margin: 52.73% > 18% (prev 59.78%; Δ -7.05% > 0.5%) |
| Asset Turnover: 41.11% > 50% (prev 38.89%; Δ 2.21% > 0%) |
| Interest Coverage Ratio: 4.63 > 6 (EBIT TTM 1.12b / Interest Expense TTM 241.7m) |
| A: 0.08 (Total Current Assets 2.02b - Total Current Liabilities 1.05b) / Total Assets 12.0b |
| B: 0.26 (Retained Earnings 3.10b / Total Assets 12.0b) |
| C: 0.10 (EBIT TTM 1.12b / Avg Total Assets 11.5b) |
| D: 0.67 (Book Value of Equity 4.75b / Total Liabilities 7.13b) |
| Altman-Z'' = 2.72 = A |
| DSRI: 0.97 (Receivables 1.05b/973.6m, Revenue 4.73b/4.26b) |
| GMI: 1.13 (GM 59.78% / 52.73%) |
| AQI: 1.00 (AQ_t 0.81 / AQ_t-1 0.81) |
| SGI: 1.11 (Revenue 4.73b / 4.26b) |
| TATA: -0.03 (NI 704.6m - CFO 1.02b) / TA 12.0b) |
| Beneish M = -2.85 (Cap -4..+1) = A |
As of June 16, 2026, the stock is trading at USD 67.31 with a total of 2,791,415 shares traded.
Over the past week, the price has changed by -2.18%,
over one month by +1.76%,
over three months by -4.64% and
over the past year by -21.14%.
TransUnion has received a consensus analysts rating of 4.20. Therefore, it is recommended to buy TRU.
- StrongBuy: 10
- Buy: 5
- Hold: 4
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 90.1 | 33.9% |
P/E Trailing = 18.1302
P/E Forward = 13.624
P/S = 2.6699
P/B = 2.6647
P/EG = 1.0485
Revenue TTM = 4.73b USD
EBIT TTM = 1.12b USD
EBITDA TTM = 1.71b USD
Long Term Debt = 5.40b USD (from longTermDebt, last quarter)
Short Term Debt = 224.1m USD (from shortTermDebt, last quarter)
Debt = 5.76b USD (from shortLongTermDebtTotal, last quarter) + Leases 77.2m
Net Debt = 5.03b USD (calculated: Debt 5.76b - CCE 732.5m)
Enterprise Value = 17.6b USD (12.6b + Debt 5.76b - CCE 732.5m)
Interest Coverage Ratio = 4.63 (Ebit TTM 1.12b / Interest Expense TTM 241.7m)
EV/FCF = 25.34x (Enterprise Value 17.6b / FCF TTM 696.5m)
FCF Yield = 3.95% (FCF TTM 696.5m / Enterprise Value 17.6b)
FCF Margin = 14.74% (FCF TTM 696.5m / Revenue TTM 4.73b)
Net Margin = 14.91% (Net Income TTM 704.6m / Revenue TTM 4.73b)
Gross Margin = 52.73% ((Revenue TTM 4.73b - Cost of Revenue TTM 2.23b) / Revenue TTM)
Gross Margin QoQ = 58.30% (prev 59.35%)
Tobins Q-Ratio = 1.46 (Enterprise Value 17.6b / Total Assets 12.0b)
Interest Expense / Debt = 4.19% (Interest Expense 241.7m / Debt 5.76b)
Taxrate = 18.19% (159.6m / 877.2m)
NOPAT = 915.4m (EBIT 1.12b * (1 - 18.19%))
Current Ratio = 1.93 (Total Current Assets 2.02b / Total Current Liabilities 1.05b)
Debt / Equity = 1.21 (Debt 5.76b / totalStockholderEquity, last quarter 4.75b)
Debt / EBITDA = 2.95 (Net Debt 5.03b / EBITDA 1.71b)
Debt / FCF = 7.22 (Net Debt 5.03b / FCF TTM 696.5m)
Total Stockholder Equity = 4.55b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.13% (Net Income 704.6m / Total Assets 12.0b)
RoE = 15.50% (Net Income TTM 704.6m / Total Stockholder Equity 4.55b)
RoCE = 11.25% (EBIT 1.12b / Capital Employed (Equity 4.55b + L.T.Debt 5.40b))
RoIC = 8.33% (NOPAT 915.4m / Invested Capital 11.0b)
WACC = 8.25% (E(12.6b)/V(18.4b) * Re(10.45%) + D(5.76b)/V(18.4b) * Rd(4.19%) * (1-Tc(0.18)))
Discount Rate = 10.45% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 6.82 | Cagr: 0.09%
[DCF] Terminal Value 77.97% ; FCFF base≈621.6m ; Y1≈712.5m ; Y5≈1.05b
[DCF] Fair Price = 55.76 (EV 15.8b - Net Debt 5.03b = Equity 10.8b / Shares 192.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 98.80 | EPS CAGR: 11.89% | SUE: 2.11 | # QB: 5
Revenue Correlation: 99.50 | Revenue CAGR: 8.85% | SUE: 2.17 | # QB: 5
EPS current Quarter (2026-06-30): EPS=1.15 | Chg30d=+0.31% | Revisions=-27% | Analysts=18
EPS next Quarter (2026-09-30): EPS=1.23 | Chg30d=+0.22% | Revisions=-25% | Analysts=18
EPS current Year (2026-12-31): EPS=4.78 | Chg30d=+0.21% | Revisions=+0% | GrowthEPS=+11.1% | GrowthRev=+12.2%
EPS next Year (2027-12-31): EPS=5.58 | Chg30d=+0.01% | Revisions=+7% | GrowthEPS=+16.8% | GrowthRev=+7.9%
[Analyst] Revisions Ratio: -27%